The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis

Hepatology

Volumn 48, Issue 4, 2008, Pages 1251-1261

  Perugorria, Maria J ^a   Latasa, M Ujue ^a   Nicou, Alexandra ^a   Cartagena Lirola, Hugo ^a   Castillo, Josefa ^a   Goñi, Saioa ^a   Vespasiani Gentilucci, Umberto ^b   Zagami, Maria G ^b   Lotersztajn, Sophie ^c,d,e   Prieto, Jesús ^a,f   Berasain, Carmen ^a   Avila, Matias A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c INSERM   (France)

^d FACULTÉ DE MÉDECINE   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMPHIREGULIN; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; CARBON TETRACHLORIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOPROTEIN; LIGAND; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE MARKER; FIBROGENESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; KUPFFER CELL; LIVER CELL; LIVER FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; APOPTOSIS; CELL CULTURE; CELL LINE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; EXTRACELLULAR MATRIX; GENETICS; LIVER; LIVER CIRRHOSIS; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CARBON TETRACHLORIDE; CELL LINE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; GLYCOPROTEINS; HEPATOCYTES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; LIVER; LIVER CIRRHOSIS; MALE; MICE; MICE, KNOCKOUT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 54449093971     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.22437     Document Type: Article

References (44)

1. Bedossa P, Paradis V. Liver extracellular matrix in health and disease. J Pathol 2003;200:504-515.
2. Iredale JP. Models of liver fibrosis: Exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 2007;117:539-548.
3. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.
4. Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Hepatic fibrosis: Molecular mechanisms and drug targets. Annu Rev Pharmacol Toxicol 2005;45:605-628.
5. Guyot C, Lepreux S, Combe C, Doudnikoff E, Bioulac-Sage P, Balabaud C, et al. Hepatic fibrosis and cirrhosis: The (myo)fibroblastic cell subpopulations involved. Int J Biochem Cell Biol 2006;38:135-151.
6. Knittel T, Kobold D, Piscaglia F, Saile B, Neubauer K, Mehde M, et al. Localization of liver myofibroblasts and hepatic stellate cells in normal and diseased rat livers: Distinct roles of (myo-) fibroblasts subpopulations in hepatic tissue repair. Histochem Cell Biol 1999;112:387-401.
7. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofibroblasts subpopulations in fibrotic human and rat livers. J Hepatol 2002;36:200-209.
8. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J Cell Mol Med 2006;10:76-99.
9. Hui AY, Friedman SL. Molecular basis of hepatic fibrosis. Expert Rev Mol Med 2003;5:1-23.
10. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989;84: 1786-1793.
11. Svegliati-Baroni G, Ridolfi F, Hannivoort R, Saccomanno S, Homan M, De Minicis S, et al. Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor. Gastroenterology 2005; 128:1042-1055.
12. Bachem MG, Meyer D, Melchior R, Sell KM, Gressner AM. Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. J Clin Invest 1992;89:19-27.
13. Bachem MG, Riess U, Gressner AM. Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta. Biochem Biophys Res Commun 1989;162:708-714.
14. Yang C, Zeisberg M, Mosterman B, Sudhakar A, Yerramalla U, Holthaus K, et al. Liver fibrosis: Insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003;124:147-159.
15. Berasain C, Castillo J, Prieto J, Avila MA. New molecular targets for hepatocellular carcinoma: The Erbb1 signaling system. Liver Int 2007;27: 174-185.
16. Berasain C, García-Trevijano ER, Castillo J, Erroba E, Lee DC, Prieto J, et al. Amphiregulin: An early trigger for liver regeneration in mice. Gastroenterology 2005;128:424-432.
17. Berasain C, García-Trevijano ER, Castillo J, Erroba E, Santamaría M, Lee DC, et al. Novel role for amphiregulin in protection from liver injury. J Biol Chem 2005;280:19012-19020.
18. Blobel CP. ADAMs: Key components in EGFR signalling and development. Nat Rev Mol Cell Biol 2005;6:32-43.
19. Wong FW, Chan WY, Lee SS. Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. Toxicol Appl Pharmacol 1998;153:109-118.
20. 4-induced fibrotic rat livers. HEPATOLOGY 1996;23:1538-1545.
21. Hemann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis-a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol 2007;46:955-975.
22. Jeong W, Park O, Radaeva S, Gao B. STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity. HEPATOLOGY 2006;44:1441-1451.
23. Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 2005;10:927-939.
24. Novo E, Marra F, Zamara E, Valfrè-Bonzo L, Monitillo L, Cannito S, et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: Resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 2006;55:1174-1182.
25. Godichaud S, Si-Tayeb K, Augé N, Desmoulière A, Balabaud C, Payrastre B, et al. The grape-derived polyphenol resveratrol differentially affects epidermal and platelet-derived growth factor signaling in human liver myofibroblasts. Int J Biochem Cell Biol 2006;38:629-637.
26. Zhou Y, Zheng S, Lin J, Zhang QJ, Chen A. The interruption of the PDGF and EGF signalling pathways by curcumin stimulates gene expression of PPARγ in rat activated hepatic stellate cell in vitro. Lab Invest 2007;87:488-498.
27. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGFα and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995;96:2461-2468.
28. Reif S, Lang A, Lindquist JN, Yata Y, Gabele E, Scanga A, et al. The role of focal adhesion kinase-phosphatidylinositol 3-kinase-Akt signaling in hepatic stellate cell proliferation and type I collagen expression. J Biol Chem 2003;278:8083-8090.
29. Gressner AM. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol 1995;22:28-36.
30. Seki E, De Minicis S, Österreicher C, Kluwe J, Osawa Y, Brenner DA, et al. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat Med 2007;13: 1324-1332.
31. Fallowfield JA, Mizuno M, Kendall TJ, Constandinou CM, Benyon RC, Duffield JS, et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 2007;178:5288-5295.
32. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, et al. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: Implications for reversibility of liver fibrosis. J Biol Chem 2002; 277:11069-11076.
33. Cao Q, Mak KM, Ren C, Lieber CS. Leptin stimulates tissue inhibitor of metalloproteinase-1 in human hepatic stellate cells. J Biol Chem 2004;279: 4292-4304.
34. Nieto N. Oxidative-stress and IL-6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells. HEPATOLOGY 2006;44:1478-1501.
35. George J, Tsutsumi M. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther 2007;14:790-803.
36. Paradis V, Dargere D, Bonvoust F, Viaud M, Segarini P, Bedossa P. Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest 2002;82:767-774.
37. Bachem MG, Meyer D, Schäfer W, Riess U, Melchior R, Sell KM, et al. The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with their transdifferentiation into myofibroblast-like cells in culture. J Hepatol 1993;18:40-52.
38. Marra F, Arrighi MC, Fazi M, Caligiuri A, Pinzani M, Romanelli RG, et al. Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. HEPATOLOGY 1999;30:951-958.
39. Saxena NK, Titus MA, Ding X, Floyd J, Srinivasan S, Sitaraman SV, et al. Leptin as a novel profibrogenic cytokine in hepatic stellate cells: mitogenesis and inhibition of apoptosis mediated by extracellular regulated kinase (Erk) and Akt phosphorylation. FASEB J 2004;18:1612-1614.
40. Davaille J, Li L, Mallat A, Lotersztajn S. Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J Biol Chem 2002;277:37323-37330.
41. Madtes DK, Elston AL, Hackman RC, Dunn AR, Clark JG. Transforming growth factor-α deficiency reduces pulmonary fibrosis in transgenic mice. Am J Respir Cell Mol Biol 1999;20:924-934.
42. Lautrette A, Li S, Alili R, Sunnarborg SW, Burtin M, Lee DC, et al. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: A new therapeutic approach. Nat Med 2005;11:867-874.
43. François H, Placier S, Flamant M, Tharaux PL, Chansel D, Dussaule JC, et al. Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition. FASEB J 2004;18:926-928.
44. Schiffer E, Housset C, Cacheux W, Wendum D, Desbois-Mouthon C, Rey C, et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. HEPATOLOGY 2005;41: 307-314.